仁和药业: 半年报监事会决议公告

Core Points - The company held its 10th Supervisory Board's second meeting on August 22, 2026, where all five supervisors attended and approved several key proposals [1][2] - The Supervisory Board approved the full and summary report of the company's 2025 semi-annual report, confirming that the report accurately reflects the company's operational and financial status without any false statements or omissions [1][2] - The Supervisory Board also approved a special report on the storage and use of funds raised in the first half of 2025, concluding that the company's practices comply with relevant regulations and do not harm investor interests [2]